In the BioHarmony Drug Report Database
Mycophenolic acid
Myfortic (mycophenolic acid) is a small molecule pharmaceutical. Mycophenolic acid was first approved as Myfortic on 2004-02-27. It is used to treat graft vs host disease and psoriasis in the USA. The pharmaceutical is active against inosine-5′-monophosphate dehydrogenase 2 and inosine-5′-monophosphate dehydrogenase 1.
Trade Name
|
Myfortic |
|---|---|
Common Name
|
mycophenolic acid |
ChEMBL ID
|
CHEMBL866 |
Indication
|
graft vs host disease, psoriasis |
Drug Class
|
Image (chem structure or protein)